Mymetics Corp MYMX:OTCQB

RT Quote | Exchange | USD
Last | 06/24/22 EDT
0.053quote price arrow down-0.006 (-10.1695%)
Volume
10,555
52 week range
0.02 - 0.12
Loading...
  • Open0.049
  • Day High0.053
  • Day Low0.049
  • Prev Close0.059
  • 52 Week High0.12
  • 52 Week High Date03/24/22
  • 52 Week Low0.02
  • 52 Week Low Date12/29/21

Key Stats

  • Market Cap16.10M
  • Shares Out303.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change60.61

KEY STATS

  • Open0.049
  • Day High0.053
  • Day Low0.049
  • Prev Close0.059
  • 52 Week High0.12
  • 52 Week High Date03/24/22
  • 52 Week Low0.02
  • 52 Week Low Date12/29/21
  • Market Cap16.10M
  • Shares Out303.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change60.61

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-3.10
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.606M
  • ROE (TTM)-
  • Revenue (TTM)820,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-601.15%
  • Debt To Equity (MRQ)-111.26%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mymetics Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and...
Ronald Kempers
President, Chief Executive Officer, Chief Financial Officer
Address
Route De La Corniche 4
Epalinges
1066
Switzerland